Conditional copula models for correlated survival endpoints: Individual patient data meta-analysis of randomized controlled trials.

Correlations among survival endpoints are important for exploring of the true endpoint. With a valid surrogate endpoint tightly correlated with the true endpoint, the efficacy of a new drug/treatment can be measurable on it. However, the existing methods for measuring correlation between two endpoints impose an invalid assumption: correlation structure is constant across different treatment arms. In this article, we reconsider the definition of Kendall's concordance measure (tau) in the context of individual patient data meta-analyses of randomized controlled trials. According to our new definition of Kendall's tau, its value depends on the treatment arms. We then suggest extending the existing copula (and frailty) models so that their Kendall's tau can vary across treatment arms. Our newly proposed model, a , is the implementation of the new definition of Kendall's tau in meta-analyses. In order to facilitate our approach, we develop an original R function and make it available in the R package (https://CRAN.R-project.org/package=joint.Cox). We apply the proposed method to a gastric cancer dataset (3288 patients in 14 randomized trials from the GASTRIC group). This data analysis concludes that Kendall's tau has different values between the surgical treatment arm and the adjuvant chemotherapy arm (-value<0.001), whereas disease-free survival remains a valid surrogate at individual level for overall survival in these trials.